Renal Cancer - Results from #840

Genomic profiles of renal cell carcinoma in a small Chinese cohort. July 11, 2023

Late complications and 5 years outcomes of robotic partial nephrectomy in France: prospective assessment in the French Kidney Cancer Research Network (UroCCR 10). July 10, 2023

Circulating antigen-primed cytotoxic T-cells in patients with renal tumors treated with surgery. July 10, 2023

Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial. July 10, 2023

Papillary Renal Cell Carcinoma: A Review of Prospective Clinical Trials. July 7, 2023

Survival in Metastatic Renal Cell Carcinoma Treated With Immunotherapy and Stereotactic Radiation Therapy or Immunotherapy Alone: A National Cancer Database Analysis. July 7, 2023

Changes in Perception of Cure Among Patients With Genitourinary Cancers Initiating Immune Checkpoint Inhibitors: A Longitudinal Study. July 6, 2023

Techniques and outcomes of percutaneous tumour ablation for small renal masses. July 6, 2023

Comparison and validation of different risk models for papillary renal cell carcinoma. July 5, 2023

The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies. July 5, 2023

Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma. July 4, 2023

Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma. July 4, 2023

Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study. July 2, 2023

Efficacy and safety of MWA versus RFA and CA for renal tumors: A systematic review and meta-analysis of comparison studies. July 2, 2023

A self-supervised vision transformer to predict survival from histopathology in renal cell carcinoma. June 30, 2023

Complications after Nephron-sparing Interventions for Renal Tumors: Imaging Findings and Management. June 30, 2023

A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. June 29, 2023

Clinical Performance of Technetium-99m-Sestamibi SPECT/CT Imaging in Differentiating Oncocytic Tumors from Renal Cell Carcinoma in Routine Clinical Practice. June 29, 2023

Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive Nephrectomy. June 28, 2023

Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy. June 28, 2023

Page 43 of 456